Today Biognosys announces the release of a new version of QuiC – an easy to use tool to monitor performance of your proteomics workflows over time. QuiC automatically analyzes MRM, PRM, DDA and DIA data and extracts LC and MS performance indicators such as the identifications in DDA mode, mass calibration or LC peak capacity. QuiC features: Management of […]
Wädenswil & Villigen, Switzerland – Creoptix and leadXpro AG announce the selection of the Creoptix WAVE technology by leadXpro to strengthen its capabilities for drug discovery aimed at identifying and optimizing drug candidates directed against challenging membrane protein drug targets. Creoptix provides leadXpro with the Creoptix WAVEdelta system, its latest technology for real-time label-free molecular interaction […]
BURLINGAME, Calif. – Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces the TrueVIEW™ Autofluorescence Quenching Kit, offering the first effective technique for removing unwanted fluorescence in formalin-fixed paraffin embedded (FFPE) tissue samples, blood cells and structural elements such as collagen and elastin. Autofluorescence often impairs or […]
Creoptix AG proudly announces the entering of the attractive UK market with Mologic as its first UK-based customer. Creoptix’ WAVEdelta system will be used at Mologic’s Centre for Advanced Rapid Diagnostics (“CARD”) in support of their ambitious assay development program. CARD is supported by a grant from the Bill & Melinda Gates Foundation and aims […]
Biognosys AG announced today a breakthrough in the development of its next generation proteomics technology that helps scientists to understand complex biological processes. For the first time, Biognosys’ data-independent acquisition (DIA) mass spectrometry workflow has identified and quantified more peptides than sequentially possible with data dependent acquisition (DDA) on a Thermo Scientific™ Q Exactive™ HF. […]
Tucson, U.S. and Salzburg, Austria – 3dbiosurfaces and STRATEC Consumables GmbH, a wholly owned subsidiary of STRATEC, announced today the release of the first commercially available microarray substrate based on 3dbiosurfaces patented and patent-pending technologies. The 3D NS-NC slide provides enormous benefits for both DNA/RNA and protein microarrays at attractive prices. The slide offers greatly […]
Genovis continues to expand in Asia and has signed a distribution agreement with Shanghai Titan Scientific Ltd. A growing number of companies in China are focusing on biopharmaceuticals, at the same time that global pharmaceutical companies are locating their process development and production in the area. Consequently there is a strong need for Genovis’ products […]
Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, announced the opening of its new office in Japan and new London location today. The new Tokyo office, right in the heart of the city, is Unchained Labs’ 6th office worldwide. Unchained Labs is headquartered […]
As of October 2017 Micronit, Axxicon and Helvoet are collaborating in offering a market leading development and manufacturing package to support the growing global demand for high volume polymer microfluidic products. The strong market growth is driven by the new fast diagnostic systems being developed and entering the health care market. At the same time […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
